Loading...
XASEDSS
Market cap6mUSD
Dec 23, Last price  
0.87USD
1D
5.07%
1Q
-30.94%
Jan 2017
-99.78%
Name

Dss Inc

Chart & Performance

D1W1MN
XASE:DSS chart
P/E
P/S
0.20
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
65.45%
Rev. gr., 5y
10.32%
Revenues
30m
-36.04%
1,594,7681,749,8644,834,4245,991,1966,643,0079,911,69113,381,58113,383,60417,115,00017,453,00018,287,00017,505,00019,177,00018,662,00018,515,08219,409,23017,411,00020,275,00047,307,00030,258,000
Net income
-81m
L+15.71%
-1,703,866-2,842,790-4,832,366-6,986,830-8,285,142-3,990,013-4,603,890-3,222,146-4,281,0002,594,000-41,157,000-14,309,000-950,000-578,0001,464,969-2,889,1473,086,000-34,050,000-69,662,000-80,606,000
CFO
-19m
L-28.79%
-1,424,196-1,689,721-1,411,677-3,219,322-2,390,771-1,595,101-1,759,253-2,124,505-3,163,283-3,149,239-2,390,238-976,6305,466,525-1,367,530-1,382,921-5,342,874-6,152,000-8,805,000-26,953,000-19,194,000
Earnings
Mar 25, 2025

Profile

DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged in—nonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
IPO date
Oct 27, 1993
Employees
119
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
30,258
-36.04%
47,307
133.33%
20,275
16.45%
Cost of revenue
44,104
86,946
35,754
Unusual Expense (Income)
NOPBT
(13,846)
(39,639)
(15,479)
NOPBT Margin
Operating Taxes
4
172
(4,032)
Tax Rate
NOPAT
(13,850)
(39,811)
(11,447)
Net income
(80,606)
15.71%
(69,662)
104.59%
(34,050)
-1,203.37%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,519
121,736
BB yield
-0.41%
-351.58%
Debt
Debt current
48,462
47,957
4,309
Long-term debt
21,971
26,617
56,344
Deferred revenue
(4,190)
Other long-term liabilities
507
880
Net debt
52,429
26,281
(22,195)
Cash flow
Cash from operating activities
(19,194)
(26,953)
(8,805)
CAPEX
(818)
(2,802)
(32,393)
Cash from investing activities
8,936
(17,969)
(119,008)
Cash from financing activities
(2,417)
7,617
179,225
FCF
(8,746)
(98,923)
(27,618)
Balance
Cash
6,615
19,290
56,595
Long term investments
11,389
29,003
26,253
Excess cash
16,491
45,928
81,834
Stockholders' equity
(236,750)
(160,445)
(57,972)
Invested Capital
382,793
382,481
312,862
ROIC
ROCE
EV
Common stock shares outstanding
6,996
111,622
2,576
Price
2.40
-26.77%
3.28
-75.60%
13.44
-89.23%
Market cap
16,805
-95.41%
366,121
957.38%
34,625
-7.81%
EV
88,520
423,521
48,839
EBITDA
(8,640)
(26,714)
(11,157)
EV/EBITDA
Interest
553
2,910
196
Interest/NOPBT